Leqembi Archives - MedicalAdvancesToday

5 min 0

Drug Development

For the first time in 20 years, FDA fully approved a new drug for Alzheimer’s disease

Justin Cheng
July 7, 2023

Leqembi is a drug that targets the underlying pathological process of Alzheimer's disease and shows clinical benefit in this disease for the first time.

Tag: Leqembi

For the first time in 20 years, FDA fully approved a new drug for Alzheimer’s disease

Healthy gut bacteria can help fight cancer elsewhere in the body

Only one mRNA vaccine shot can reduce HPV-related tumors, and the effect is better than DNA or recombinant protein vaccines

A 10-year follow-up study of nearly 13,000 people found that regular vitamin D supplementation reduces the risk of dementia by 40%

Researchers revealed the B cell mechanism of autoimmunity triggered by the clearance of susceptible macrophages in lymph nodes

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

For the first time in 20 years, FDA fully approved a new drug for Alzheimer’s disease

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study